WATERLOO, Ontario--An agreement signed last week will give Allelix Biopharmaceuticals early access to Biomedical Photometrics' patented Genescope technology for reading genetic microarrays. Allelix will evaluate a preproduction version of the Genescope instrument to help accelerate its existing drug discovery programs, and will provide funding during this period. Both companies will share the rights to any inventions developed during the collaboration.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.